We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Experimental Drug Delivers One-Two Punch to Vision Loss

News   Apr 11, 2019 | Original story from Johns Hopkins Medicine

 
Experimental Drug Delivers One-Two Punch to Vision Loss

Images of the mouse retina with a fluorescent fluid tracer. Diseased blood vessels allow the tracer to permeate nearby tissues. Vessels treated with AXT107 do not allow fluids to escape and exhibit clean crisp borders with surrounding tissue. Credit: Alexsander Popel

 
 
 

RELATED ARTICLES

Liver Fibrosis “Off Switch” Could Help Fight Alcoholic Liver Disease

News

Understanding the process of liver fibrosis, could help researchers develop new ways to prevent or treat conditions such as alcoholic liver disease. A team has now demonstrated for the first time that liver fibrosis progression could potentially be targeted by manipulating a special population of liver cells.

READ MORE

Taking Aim at Gastric Cancer

News

A team has discovered that a novel drug, called “FerriIridium”, is capable of simultaneously diagnosing and treating gastric cancer.

READ MORE

Curvy Cancer-causing Bacterium "Keeps in Shape”

News

New insights into how the cancer-causing stomach bacterium keeps its shape could pave the way for the creation of more-specialized antibiotics.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE